Viking Therapeutics: Partnerships, Abstracts, And Endpoints
Viking Therapeutics: Partnerships, Abstracts, And Endpoints.....»»
Viking Therapeutics reports Q4 EPS (10c), consensus (13c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics (VKTX) Shares Cross Below 200 DMA
Market News Video.....»»
Axsome Therapeutics announces AXS-07 met primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy?
“The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels.....»»
Viking Therapeutics management to meet with SVB Leerink
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics (VKTX) Shares Cross Above 200 DMA
Market News Video.....»»
I"m Picking Viking Therapeutics For NASH
I"m Picking Viking Therapeutics For NASH.....»»
Data on Viking Therapeutics" VK2809 study in NASH posted to ClinicalTrials.gov
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics begins Phase 2b clinical trial of VK2809
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Were Hedge Funds Right About Souring On Viking Therapeutics, Inc. (VKTX)?
Is Viking Therapeutics, Inc. (NASDAQ:VKTX) a good place to invest some of your money right now? We can gain invaluable insight to help .....»»
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2019 Results - Earnings Call Transcript
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2019 Results - Earnings Call Transcript.....»»
Viking Therapeutics reports Q3 EPS (8c), consensus (13c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aclaris Therapeutics Phase 3 THWART-1 trial meets primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics management to meet with Needham
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics" (VKTX) CEO Brian Lian on Q2 2019 Results - Earnings Call Transcript
Viking Therapeutics" (VKTX) CEO Brian Lian on Q2 2019 Results - Earnings Call Transcript.....»»
Viking Therapeutics reports Q2 EPS (11c), consensus (9c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics management to meet with Needham
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics management to meet with B. Riley FBR
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viking Therapeutics started at outperform with $12 stock price target at Oppenheimer
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Viking Therapeutics initiated with an Outperform at Oppenheimer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»